Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds HC Wainwright & Co. Reiterates Buy on Kiora Pharmaceuticals, Maintains $10 Price Target

HC Wainwright & Co. Reiterates Buy on Kiora Pharmaceuticals, Maintains $10 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates Kiora Pharmaceuticals (NASDAQ:KPRX) with a Buy and maintains $10 price target.

February 8, 2023

1 minute read

HC Wainwright & Co. analyst Yi Chen reiterates Kiora Pharmaceuticals (NASDAQ:KPRX) with a Buy and maintains $10 price target.

Warren Buffett Donates $759M In Berkshire Shares To Family Charities: How Much Stake Is He Left With?

November 23, 9:13 PM

Berkshire Hathaway Inc (NYSE: BRK-A) (NYSE: BRK-B) Chair Warren Buffett donated Class B shares of the company

August 4, 12:01 PM

ProShares and Bitwise have submitted proposals to the U.S.

November 9, 4:05 PM

Builders FirstSource (NYSE:BLDR) has observed the following analyst ratings within the last quarter:

July 15, 10:26 AM

Morgan Stanley analyst Jeffrey Hung maintains Evofem Biosciences (NASDAQ:EVFM) with a Underweight and lowers the price target from $2 to $0.75.